Emerging Role of Aprepitant in Cannabis Hyperemesis Syndrome

Cannabis hyperemesis syndrome (CHS) is a clinical syndrome associated with prolonged and regular cannabis use. CHS is characterized by recurrent episodes of intractable nausea and vomiting. Given the overlap with other medical conditions and the frequent delay in diagnosis, finding an effective anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Parvataneni, Swetha, Varela, Lionel, Vemuri-Reddy, Sireesha M, Maneval, Mandy L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Family/General Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682377/
https://www.ncbi.nlm.nih.gov/pubmed/31403013
http://dx.doi.org/10.7759/cureus.4825
Descripción
Sumario:Cannabis hyperemesis syndrome (CHS) is a clinical syndrome associated with prolonged and regular cannabis use. CHS is characterized by recurrent episodes of intractable nausea and vomiting. Given the overlap with other medical conditions and the frequent delay in diagnosis, finding an effective anti-emetic regimen for symptomatic control of CHS can be challenging. We report a case study where aprepitant (Emend) was successfully used as an anti-emetic in the treatment of CHS when all other common anti-emetics failed.

Ejemplares similares